A Study of Safety, Tolerability, PK, and PD of Subcutaneous GenSci136 in Healthy Adults.

Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA Vaccine

NCT05366296 ·Status: WITHDRAWN ·Phase: PHASE1

GLS-5310 Vaccine in Healthy Volunteers for the Prevention of SARS-CoV-2 (COVID-19)

NCT05085639 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects

NCT02669667 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate Safety and Tolerability of mRNA-0184 Administered Subcutaneously in Healthy Participants

NCT06655870 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Immunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above

NCT05663086 ·Status: WITHDRAWN ·Phase: PHASE2

Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above

NCT05408312 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety of MEDI7836 in Healthy Adults.

NCT02388347 ·Status: COMPLETED ·Phase: PHASE1

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

NCT04655625 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Older Adults.

NCT05354063 ·Status: UNKNOWN ·Phase: PHASE1

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

NCT01544361 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

NCT05043311 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Adults Aged 18 -59 Years.

NCT05354089 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Vaccine Boosters

NCT05137236 ·Status: COMPLETED ·Phase: PHASE2

PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64

NCT04765436 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without High-Risk Conditions for Severe Coronavirus Disease 2019 (COVID-19)

NCT07266558 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

A Phase 2 Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants

NCT07205796 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19

NCT05102643 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)

NCT04352608 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant Vaccine

NCT05313035 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

NCT03159364 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)

NCT04813562 ·Status: UNKNOWN ·Phase: PHASE2

A Phase I/II Study to Evaluate a SARS-CoV-2 mRNA Vaccine in Healthy Adults

NCT05903118 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19

NCT05656443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Phase I Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

NCT05373485 ·Status: COMPLETED ·Phase: PHASE1

A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or More

NCT05439824 ·Status: UNKNOWN ·Phase: PHASE2